» Articles » PMID: 34113664

Etiology-Discriminative Multimodal Imaging of Left Ventricular Hypertrophy and Synchrotron-Based Assessment of Microstructural Tissue Remodeling

Abstract

Distinguishing the etiology of left ventricular hypertrophy (LVH) is clinically relevant due to patient outcomes and management. Easily obtained, echocardiography-based myocardial deformation patterns may improve standard non-invasive phenotyping, however, the relationship between deformation phenotypes and etiology-related, microstructural cardiac remodeling has not been reported. Synchrotron radiation-based X-ray phase-contrast imaging (X-PCI) can provide high resolution, three-dimensional (3D) information on myocardial microstructure. The aim of this pilot study is to apply a multiscale, multimodality protocol in LVH patients undergoing septal myectomy to visualize and myocardial tissue and relate non-invasive LVH imaging phenotypes to the underlying synchrotron-assessed microstructure. Three patients (P1-3) undergoing septal myectomy were comprehensively studied. Medical history was collected, and patients were imaged with echocardiography/cardiac magnetic resonance prior to the procedure. Myocardial tissue samples obtained during the myectomy were imaged with X-PCI generating high spatial resolution images (0.65 μm) to assess myocyte organization, 3D connective tissue distribution and vasculature remodeling. Etiology-centered non-invasive imaging phenotypes, based on findings of hypertrophy and late gadolinium enhancement (LGE) distribution, and enriched by speckle-tracking and tissue Doppler echocardiography deformation patterns, identified a clear phenotype of hypertensive heart disease (HTN) in P1, and hypertrophic cardiomyopathy (HCM) in P2/P3. X-PCI showed extensive interstitial fibrosis with normal 3D myocyte and collagen organization in P1. In comparison, in P2/P3, X-PCI showed 3D myocyte and collagen disarray, as well as arterial wall hypertrophy with increased perivascular collagen, compatible with sarcomere-mutation HCM in both patients. The results of this pilot study suggest the association of non-invasive deformation phenotypes with etiology-related myocyte and connective tissue matrix disorganization. A larger patient cohort could enable statistical analysis of group characteristics and the assessment of deformation pattern reproducibility. High-resolution, 3D X-PCI provides novel ways to visualize myocardial remodeling in LVH, and illustrates the correspondence of macrostructural and functional non-invasive phenotypes with invasive microstructural phenotypes, suggesting the potential clinical utility of non-invasive myocardial deformation patterns in phenotyping LVH in everyday clinical practice.

Citing Articles

The use of ethanol as contrast enhancer in synchrotron X-ray phase-contrast imaging leads to heterogeneous myocardial tissue shrinkage: a case report.

Bernardino G, Calvet-Mirabent A, Dejea H, Guasch E, Bonnin A, Garcia-Canadilla P J Synchrotron Radiat. 2024; 32(Pt 1):200-209.

PMID: 39689036 PMC: 11708853. DOI: 10.1107/S1600577524010221.


Risk Stratification in Hypertrophic Cardiomyopathy: Leveraging Artificial Intelligence to Provide Guidance in the Future.

Ahluwalia M, Kpodonu J, Agu E JACC Adv. 2024; 2(7):100562.

PMID: 38939491 PMC: 11198167. DOI: 10.1016/j.jacadv.2023.100562.


A tomographic microscopy-compatible Langendorff system for the dynamic structural characterization of the cardiac cycle.

Dejea H, Schleputz C, Mendez-Carmona N, Arnold M, Garcia-Canadilla P, Longnus S Front Cardiovasc Med. 2023; 9:1023483.

PMID: 36620622 PMC: 9815149. DOI: 10.3389/fcvm.2022.1023483.

References
1.
Baudry G, Mansencal N, Reynaud A, Richard P, Dubourg O, Komajda M . Global and regional echocardiographic strain to assess the early phase of hypertrophic cardiomyopathy due to sarcomeric mutations. Eur Heart J Cardiovasc Imaging. 2019; 21(3):291-298. DOI: 10.1093/ehjci/jez084. View

2.
cikes M, Sutherland G, Anderson L, Bijnens B . The role of echocardiographic deformation imaging in hypertrophic myopathies. Nat Rev Cardiol. 2010; 7(7):384-96. DOI: 10.1038/nrcardio.2010.56. View

3.
Hughes S . The pathology of hypertrophic cardiomyopathy. Histopathology. 2004; 44(5):412-27. DOI: 10.1111/j.1365-2559.2004.01835.x. View

4.
Mirea O, Pagourelias E, Duchenne J, Bogaert J, Thomas J, Badano L . Intervendor Differences in the Accuracy of Detecting Regional Functional Abnormalities: A Report From the EACVI-ASE Strain Standardization Task Force. JACC Cardiovasc Imaging. 2017; 11(1):25-34. DOI: 10.1016/j.jcmg.2017.02.014. View

5.
Hetterich H, Willner M, Fill S, Herzen J, Bamberg F, Hipp A . Phase-contrast CT: qualitative and quantitative evaluation of atherosclerotic carotid artery plaque. Radiology. 2014; 271(3):870-8. DOI: 10.1148/radiol.14131554. View